May nutritional status worsen during hospital stay? A sub-group analysis from a cross-sectional study

被引:0
作者
Emanuele Rinninella
Marco Cintoni
Antonino De Lorenzo
Gaia Anselmi
Lucilla Gagliardi
Giovanni Addolorato
Giacinto Abele Donato Miggiano
Antonio Gasbarrini
Maria Cristina Mele
机构
[1] Fondazione Policlinico Universitario A. Gemelli IRCCS,UOC di Nutrizione Clinica, Dipartimento di Scienze Gastroenterologiche, Endocrino
[2] Università Cattolica del Sacro Cuore,Metaboliche e Nefro
[3] Università di Roma Tor Vergata,Urologiche
[4] Università di Roma Tor Vergata,Istituto di Patologia Speciale Medica
来源
Internal and Emergency Medicine | 2019年 / 14卷
关键词
Nutritional status; Hospital malnutrition; Phase angle; Fat-free mass; Prognostic nutritional index; ESPEN criteria; Personalized medicine;
D O I
暂无
中图分类号
学科分类号
摘要
Hospital malnutrition is a detrimental prognostic factor regarding hospital mortality, complications, and length of stay. However, the role of hospitalization itself on nutritional status has not been fully elucidated. We report the results of a secondary analysis from the dataset of a recent cross-sectional study at Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Data from patients evaluated at admission and discharge were collected and compared. One hundred thirty-nine patients were evaluated. Mean length of stay was 13.6 (± 7.7) days. Patients at risk of malnutrition, according to NRS-2002, were 75 (53.9%), while 63 (45.3%) were malnourished according to ESPEN Criteria. Compared to admission, at discharge, patients reported a significant decrease in Mid-Upper Arm Circumference (MUAC)—from 26.5 cm (± 3.6) to 25.9 cm (± 3.7) (p = 0.016), a reduction in Phase angle (PhA)—from 4.25° (± 1.20) to 4.01° (± 1.15) (p = 0.005), fat-free mass (FFM)—from 47.5 kg (± 9.19) to 44.9 kg (± 9.4) (p = 0.03) and fat-free mass index (FFMI)—from 16.9 kg/m2 (± 2.3) to 15.8 kg/m2 (± 2.7) (p = 0.04). Laboratory data showed a reduction of albumin—from 29.2 (± 5.7) to 28.0 (± 5.9) (p = 0.01) and Onodera’s PNI- from 29.1 (± 5.6) to 27.6 kg (± 5.6) (p = 0.039). At the multivariate linear regression analysis, the variables significantly associated with a worsening of PhA at discharge are the PhA value at admission and the diagnosis of malnutrition according to ESPEN Criteria. Hospitalization leads to significative changes in nutritional status. A clinical concern should be raised about the quality of hospital food and meal times and on the need for a clinical nutritionist on the ward.
引用
收藏
页码:51 / 57
页数:6
相关论文
共 275 条
[1]  
Correia MI(2003)The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis Clin Nutr 22 235-239
[2]  
Waitzberg DL(2017)Nutritional status is a predictor of outcome in cancer patients, irrespective of stage Intern Emerg Med 12 135-136
[3]  
Laviano A(2017)ESPEN diagnostic criteria for malnutrition—a validation study in hospitalized patients Clin Nutr 36 1326-1332
[4]  
Rossi Fanelli F(2017)A novel in-hospital meal service improves protein and energy intake Clin Nutr 36 149-165
[5]  
Guerra RS(2017)Whey protein supplementation improves rehabilitation outcomes in hospitalized geriatric patients: a double blinded, randomized controlled trial J Nutr Gerontol Geriatr 7 75-76
[6]  
Fonseca I(2012)Timing of the initiation of parenteral nutrition in critically ill adults Intern Emerg Med 10 E246-81
[7]  
Sousa A(2018)Cost-effectiveness of a specialized oral nutritional supplementation for malnourished older adult patients in Spain Nutrients 50 74-432
[8]  
Jesus A(2018)NutriCatt protocol in the enhanced recovery after surgery (ERAS) program for colorectal surgery: the nutritional support improves clinical and cost-effectiveness outcomes Nutrition 21 421-39
[9]  
Pichel F(2018)Large regional disparities in prevalence, management and reimbursement of hospital undernutrition Eur J Clin Nutr 32 30-211
[10]  
Amaral TF(2017)Nutritional support in acute pancreatitis: from physiopathology to practice. An evidence-based approach Eur Rev Med Pharmacol Sci 13 205-421